Literature DB >> 8316303

Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid.

J C Vera1, C I Rivas, J Fischbarg, D W Golde.   

Abstract

Although vitamin C is critical to human physiology, it is not clear how it is taken up into cells. The kinetics of cell and tissue accumulation of ascorbic acid in vitro indicate that the process is mediated by specific transporters at the cell membrane. Some experimental observations have linked the transport of ascorbic acid with hexose transport systems in mammalian cells, although no clear information is available regarding the specific role(s) of these transporters, if any, in this process. Here we use the Xenopus laevis oocyte expression system to show that the mammalian facilitative hexose transporters are efficient transporters of the oxidized form of vitamin C (dehydroascorbic acid). Two transport pathways, one with low affinity and one with high affinity for dehydroascorbic acid, were found in oocytes expressing the mammalian transporters, and these oocytes accumulated vitamin C against a concentration gradient when supplied with dehydroascorbic acid. We obtained similar results in experiments using normal human neutrophils. These observations indicate that mammalian facilitative hexose transporters are a physiologically significant pathway for the uptake and accumulation of vitamin C by cells, and suggest a mechanism for the accumulation of ascorbic acid against a concentration gradient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316303     DOI: 10.1038/364079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  108 in total

1.  Moderately controlled transport of ascorbate into aortic endothelial cells against slowdown of the cell cycle, decreasing of the concentration or increasing of coexistent glucose as compared with dehydroascorbate.

Authors:  Y Saitoh; N Nagao; R O'Uchida; T Yamane; K Kageyama; N Muto; N Miwa
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome.

Authors:  J Klepper; D Wang; J Fischbarg; J C Vera; I T Jarjour; K R O'Driscoll; D C De Vivo
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 3.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 4.  Targeting cancer vulnerabilities with high-dose vitamin C.

Authors:  Bryan Ngo; Justin M Van Riper; Lewis C Cantley; Jihye Yun
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

5.  Recycling processes of cellular ascorbate generate oxidative stress in pancreatic tissues in in vitro system.

Authors:  Shelley Brown; Maria Georgatos; Conrad Reifel; Jih H Song; Seon H Shin; Murray Hong
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

6.  Assessing the reductive capacity of cells by measuring the recycling of ascorbic and lipoic acids.

Authors:  James M May
Journal:  Methods Mol Biol       Date:  2010

Review 7.  Role of vitamin C in the function of the vascular endothelium.

Authors:  James M May; Fiona E Harrison
Journal:  Antioxid Redox Signal       Date:  2013-05-29       Impact factor: 8.401

8.  Ascorbic acid efflux and re-uptake in endothelial cells: maintenance of intracellular ascorbate.

Authors:  James M May; Zhi-chao Qu
Journal:  Mol Cell Biochem       Date:  2009-01-09       Impact factor: 3.396

9.  Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.

Authors:  Juan M Cárcamo; Alicia Pedraza; Oriana Bórquez-Ojeda; Bing Zhang; Roberto Sanchez; David W Golde
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 10.  Sodium-dependent ascorbic acid transporter family SLC23.

Authors:  Hitomi Takanaga; Bryan Mackenzie; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2003-07-04       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.